NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, SH | - |
dc.contributor.author | Seo, DW | - |
dc.contributor.author | Ko, YK | - |
dc.contributor.author | Sung, DS | - |
dc.contributor.author | Bae, GU | - |
dc.contributor.author | Yoon, JW | - |
dc.contributor.author | Hong, SGY | - |
dc.contributor.author | Han, JW | - |
dc.contributor.author | Lee, HW | - |
dc.date.accessioned | 2021-06-24T01:08:33Z | - |
dc.date.available | 2021-06-24T01:08:33Z | - |
dc.date.issued | 1998-12 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.issn | 1976-3786 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/47013 | - |
dc.description.abstract | The enzyme responsible for the synthesis of nitric oxide (NO) from L-arginine in mammalian tissues is known as nitric oxide synthase (NOS) (EC.1.14.13.39). In the present study, the role of NO in the regulation of exocrine secretion was investigated in rat pancreatic acinar cells. Treatment of rat pancreatic acinar cells with cholecystokinin-octapeptide (CCK-OP) resulted in an increase in the arginine conversion to citrulline, the amount of NOx, the release of amylase, and the level of cGMP. Especially, CCK-OP-stimulated increase of arginine to citrulline transformation, the amount of NO, and cGMP level were completely counteracted by the inhibitor of NOS, NG-monomethyl-L-arginine (MMA), by contrast, that of amylase release was partially reduced. Furthermore, MMA-induced decrease of NOS activity and amylase release showed dose-dependent pattern. The data on the time course of CCK-OP-induced citrulline formation and cGMP rise indicate that NOS and guanylate cyclase were activated by treatment of CCK-OP. However, the mechanism of agonist-stimulated guanylate cyclase activation in acinar cells remains unknown. Therefore, activation of NOS is one of the early events in receptor-mediated cascade of reactions in pancreatic acinar cells and NO, not completely, but partially mediate pancreatic enzyme exocrine secretion. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한약학회 | - |
dc.title | NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cells | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/BF02976753 | - |
dc.identifier.scopusid | 2-s2.0-0032239443 | - |
dc.identifier.wosid | 000077549800007 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, v.21, no.6, pp 657 - 663 | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.volume | 21 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 657 | - |
dc.citation.endPage | 663 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | NITRIC-OXIDE SYNTHASE | - |
dc.subject.keywordPlus | CGMP | - |
dc.subject.keywordPlus | INFLUX | - |
dc.subject.keywordPlus | LEVEL | - |
dc.subject.keywordPlus | ENTRY | - |
dc.subject.keywordAuthor | nitric oxide | - |
dc.subject.keywordAuthor | cholecystokinin-octapeptide | - |
dc.subject.keywordAuthor | cyclic GMP | - |
dc.subject.keywordAuthor | exocrine secretion | - |
dc.identifier.url | https://link.springer.com/article/10.1007/BF02976753 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.